FdaApplication

BLA 761268

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCELLTRION, Inc.
application_typeBLA
approval_date2022-09-27

Products (2)

ProductActive ingredientStrengthDosage form
VEGZELMABEVACIZUMAB-ADCD100MG/4ML (25MG/ML)Injection
VEGZELMABEVACIZUMAB-ADCD400MG/16ML (25MG/ML)Injection

2 products